Urinary incontinence, or overactive bladder, is a distressing condition. It can interrupt even the simplest aspects of daily life and lead to embarrassing symptoms, such as leaking and wetting accidents.
Betmiga is an effective prescription treatment that resolves most cases of urinary incontinence. It is available as a tablet in two dosages - 25mg MR (modified release) and 50mg MR - and should be taken once daily.
The lower dose is for those with liver or kidney impairment.
You should first consult your doctor to determine the underlying cause of your condition.
Betmiga works by relaxing a smooth muscle called the detrusor.
The detrusor is located in the bladder wall and manages the capacity of the organ. It relaxes to store urine and contracts to induce urination.
Many cases of incontinence are a result of the detrusor being prone to over-contracting, which increases the frequency of urination.
Betmiga relaxes the detrusor, increasing the capacity of the bladder and alleviating symptoms.
You should always follow the instructions of your doctor and those detailed in the patient leaflet.
Betmiga is available in two doses: 25mg MR and 50mg MR. The standard starting dose is 50mg MR, to be taken once daily. The 25mg MR dose is prescribed to patients with mild liver or kidney impairment.
You should take doses around the same time daily. If you forget a dose, take it as soon as you remember. However, never take a double-dose to make up for a missed dose.
You should take Betmiga orally, with or without food. Do not crush, chew or split tablets.
While taking Betmiga, you should have regular check-ups with your doctor, to ensure the medication is having a positive effect.
Before taking any medication, it is important to familiarise yourself with potential side effects.
The following are the most widely reported side effects of Betmiga:
For a complete list, please consult your patient leaflet.
If you start to experience any signs of an allergic reaction (such as swelling of the face, lips, tongue, or throat, or difficulty breathing), you should seek immediate medical attention.
You should stop treatment and inform your doctor if you suffer any serious side effects.
These may include:
You should disclose all medical history during your online consultation.
There are certain conditions that may preclude you from using Betmiga. These include:
If you have mild kidney or liver impairment, the doctor may recommend a lowered dose of 25mg MR.
You should also have your blood pressure regularly checked when using this medication, particularly if you have existing hypertension.
If you are pregnant or breastfeeding, you should consult your doctor before starting this treatment.
For a full list of precautions and contraindications, please refer to the patient leaflet.
First, you select the treatment you require - in this case, Betmiga. You will then be asked to complete an online consultation. This is completely confidential, and only our doctors will review it. If they approve this treatment for your use, it will be dispatched with next-day delivery. It’s as simple as that.